|
| Objective | First-level index | Second-level index | Third-level index |
|
| Transparency of security risk information in Chinese listed pharmaceutical enterprises (S) | Government supervision information transparency (A1) | Safety supervision information (B1) | Supervision focus information (C11) |
| Administrative punishment information (C12) |
| Risk warning information (C13) |
| Supervision announcement information (C14) |
| Production and business license directory information (C15) |
| Media coverage information (C16) |
| Safety sampling information (B2) | Random inspection information (C21) |
| Test instrument information (C22) |
| Tracking inspection information (C23) |
| Chemical dangerous goods management information (C24) |
| Clinical trial information (B3) | Development method information (C31) |
| Quality index information (C32) |
| Pharmacological toxicology experimental results information (C33) |
| Clinical and nonclinical research quality management regulatory information (C34) |
| Accident emergency information (B4) | Expired product recycling system (C41) |
| Product return and recall system (C42) |
| Product accident emergency mechanism (C43) |
| Adverse drug reaction reporting system (C44) |
| Listed pharmaceutical enterprises information transparency (A2) | Enterprise basic information (B5) | Pharmaceutical production license information (C51) |
| Pharmaceutical business license information (C52) |
| Basic situation of the board of supervisors members (C53) |
| The integrity of other employees (C54) |
| Product information (B6) | Drug label and approval number (C61) |
| Drug advertisement information (C62) |
| Packaging materials and container information (C63) |
| Drug purchase inspection, acceptance and custody information (C64) |
| Safety production and sales information (B7) | Production process and records (C71) |
| Equipment information (C72) |
| Storage facilities (C73) |
| Purchase and sales records (C74) |
| Enterprise governance information (B8) | Enterprise governance framework (C81) |
| Decision-making supervision and performance of the Board of Supervisors (C82) |
| Reporting evaluations such as finance and social governance (C83) |
| Rewards and punishments of the senior executive (C84) |
| Participation of other stakeholders in governance (C85) |
| Equity concentration (C86) |
| Financial information (B9) | Return on net assets (C91) |
| Asset-liability ratio (C92) |
| Operating cash flow (C93) |
| Growth rate of gross operating income (C94) |
|
